New Mandatory Genetic Screening Policy
The Women’s Tennis Association (WTA) has introduced a policy requiring all players to undergo genetic sex testing to maintain their eligibility for the professional tour. According to reporting by Ben Rothenberg, this development marks a significant shift for the organization, which is now mandating genetic screening for all of its athletes.
The requirement is not yet featured on the public-facing WTA rulebook or website. Instead, the 2026 WTA Rulebook directs inquiries regarding the WTA Women’s Eligibility Policy
to the organization’s legal department. Athletes are now required to sign a document acknowledging that failure to undergo the testing or competing while ineligible could lead to disciplinary action, including suspension and the potential public disclosure of their status.
Comparison to the 2024 Eligibility Standards
The current mandate represents a departure from the October 2024 version of the policy, which focused on testosterone thresholds rather than mandatory genetic screening. The previous iteration explicitly sought to facilitate the participation of transgender players and those with differences of sex development, provided they maintained specific hormonal levels and signed a declaration regarding their gender identity.
In contrast, the new policy emphasizes the identification of genetic markers. While the tour has not hosted a transgender woman in nearly half a century, the implementation of these tests appears to address what some observers describe as a moral panic
surrounding the inclusion of trans women in sports, despite the absence of any active transgender competitors currently playing on the tour.
Public Reaction and Internal Dissent
The Legal and Ethical Stakes
The WTA eligibility document obtained by reporters outlines the severe consequences for non-compliance. By conditioning participation on the results of genetic screening, the tour has established a high-stakes environment where a player’s private medical data could potentially become public. The document explicitly warns players that ineligibility findings might result in public speculation.
For now, the WTA remains the first independent professional women’s sports league to mandate such comprehensive genetic screening for its entire roster, setting a precedent that diverges from the more inclusive language utilized by the organization as recently as 2024.
Future Implementation and Monitoring
With the policy now in effect, players are currently being held to these new standards. The organization has not provided a public timeline for when the full, updated policy document will be integrated into the official online rulebook, leaving the WTA Women’s Eligibility Policy
to be managed through internal channels and direct legal contact for the foreseeable future.
Sources: OPB.
Worth a look
